Healthcare-focused advisory Cello Health Group said it had delivered 'strong' net revenue and profit growth for the first quarter, but said performance in its signal business was likely to be impacted by more significant Covid-19 related disruptions than the health division. Cello signal comprised around 16% of net revenue for the first quarter. 'The group remains in a solid net cash position, after settlement earlier this month of the defined health final earn out payment of £0.7m and imminent payment of the interim dividend of 1p per share,' the company said in prepared remarks ahead of its AGM. At 9:27am: (LON:CLL) Cello Group PLC share price was +5.5p at 120p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.